Segal E, Etchepare S, Balbachan O, Broderson C
Unidad de Gastroenterología, Hospital Durand, Buenos Aires, Argentina.
Acta Gastroenterol Latinoam. 1993;23(2):87-91.
Midazolam is the benzodiazepine recommended for anaesthesia induction when an early recovering is desirable. Flumazenil, which is also a hydrosoluble imidazobenzodiazepine, improves the safety of the forhere one because it immediately reduces the degree of sedation. With this purpose, this last drug has been studied in 25 patients who had been previously treated with Midazolam in order to carry out different endoscopic studies. The Flumazenil average dose used was 0.276 mg and the conscience recovering after its intravenous injection, evaluated by a simple oral numeric regression test, oscillated between 60 and 300 seconds with an X of 96 seconds. Once the study was finished, all patients were discharged from hospital after two-hour observation, except for one patient (4%) who suffered a complication and so was discharged after a twenty-four-hour control. No doubt the advent of a drug opposed to benzodiazepine receptors used in anaesthetic induction shows the possibility of a quick recovering and moreover. Quicker discharge from hospital.
当希望早期苏醒时,咪达唑仑是推荐用于麻醉诱导的苯二氮䓬类药物。氟马西尼也是一种水溶性咪唑苯二氮䓬类药物,它提高了前一种药物的安全性,因为它能立即减轻镇静程度。出于这个目的,对25名先前接受过咪达唑仑治疗以进行不同内镜检查的患者进行了后一种药物的研究。使用的氟马西尼平均剂量为0.276毫克,通过简单的口服数字回归试验评估,静脉注射后意识恢复时间在60至300秒之间波动,平均值为96秒。研究结束后,除一名患者(4%)出现并发症,在24小时观察后出院外,所有患者在两小时观察后均出院。毫无疑问,一种与麻醉诱导中使用的苯二氮䓬受体拮抗剂的药物的出现显示了快速苏醒的可能性,而且。更快出院。